OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
Paresh Vyas is a clinical academic and Deputy Director of the MRC Molecular Haematology Unit (MHU), Weatherall Institute of Molecular Medicine (WIMM) at the University of Oxford. He is clinical lead for AML (Acute Myeloid Leukaemia) and MDS (Myelodysplasia) for Oxford and leads Phase I-III clinical trials in the UK and international in AMl and MDS. His research focuses on allo-immune responses to leukemia and the molecular and cellular biology of normal and leukaemic haemopoiesis.
